IMAGING CHARACTERISTICS OF 3.0-T MRI IN PROSTATE CANCER
Main Article Content
Abstract
Objective: To study the imaging features of 3.0-T MRI in prostate cancer (PCa). Methods: 25 patients (Pts) underwent prostate 3.0-T MRI from 03/2023 to 10/2023, with post-biopsy/surgical pathology confirming PCa. Results: The mean age of Pts was 72.6 ± 6.6 (range 59 to 82 years). The total number of detected lesions on 3.0-T MRI was 89. On T2-weighted imaging (T2W), all 44 (100%) lesions in the transition zone and 42 (93.3%) lesions in the peripheral zone showed hypointensity (p = 0.3), however, 64 (72%) lesions were homogenous, and 23% were heterogeneous (p < 0.05). On diffusion-weighted imaging (DWI), the restricted diffusion in the peripheral and transition zones indicated PCa in 38 (84.4%) and 37 (84.1%) lesions, respectively (p = 1). After dynamic contrast-enhanced (DCE) imaging, the early enhancement rate in the peripheral zone was 42.2% lesions, higher than in the transition zone at 15.9% (p < 0.05). Invasion signs included capsule interruption in 14 Pts (56%), bladder wall invasion in 12 Pts (48%), seminal vesicle invasion in 18 Pts (72%). Pelvis node extension was observed in 13 Pts (52%), and bone in 3 Pts (12%). The distribution according to Prostate Imaging-Reporting and Data System (PI-RADS) v.2.0 scores were PIRADs I and II (0%), PIRADs III in 4 Pts (16%), PIRADs IV in 9 Pts (36%), and PIRADs V in 12 Pts (48%). Conclusion: The imaging features on 3.0-T MRI are reliable in diagnosing prostate cancer.
Article Details
Keywords
Prostate cancer, 3.0-T MRI, 3.0-Tesla magnetic resonance imaging.
References
2. Nguyễn Thị Nhân, Nguyễn Thanh Hải, Lê Hồng Chiến, Ngô Văn Đoan, Vũ Thị Hậu. Giá trị bước đầu của cộng hưởng từ đa thông số theo phân loại PI-RADSv2.1 trong phát hiện ung thư tuyến tiền liệt có ý nghĩa lâm sàng Tạp chí Y học Việt Nam. 2021;500(2).
3. Holmström B, Johansson M, Bergh A, Stenman UH, Hallmans G, Stattin P. Prostate specific antigen for early detection of prostate cancer: longitudinal study. BMJ (Clinical research ed). 2009;339:b3537.
4. Chavan PR, Chavan SV, Chavan NR, Trivedi VD. Detection rate of prostate cancer using prostate specific antigen in patients presenting with lower urinary tract symptoms: a retrospective study. Journal of postgraduate medicine. 2009;55(1):17-21.
5. Nishida S, Kinoshita H, Mishima T, Kurokawa H, Sakaida N, Matsuda T. Prostate cancer detection by prebiopsy 3.0-Tesla magnetic resonance imaging. International journal of urology: official journal of the Japanese Urological Association. 2011;18(9):653-8.
6. Popita C, Popita AR, Sitar-Taut A, Petrut B, Fetica B, Coman I. 1.5-Tesla Multiparametric-Magnetic Resonance Imaging for the detection of clinically significant prostate cancer. Clujul medical (1957). 2017;90(1):40-8.
7. Trương Thị Thanh, Hoàng Đình Âu. Giá trị của cộng hưởng từ trong chẩn đoán các nhân vùng chuyển tiếp tuyến tiền liệt theo PIRADS 2.1. Tạp chí Y học Việt Nam. 2023;522(2).
8. Lee H, Hwang SI, Lee HJ, Byun SS, Lee SE, Hong SK. Diagnostic performance of diffusion-weighted imaging for prostate cancer: Peripheral zone versus transition zone. PloS one. 2018; 13(6):e0199636.